News Headlines Article

CVS to pay $5 million to settle drug pricing allegations
Modern Healthcare

The Justice Department says a unit of CVS Caremark has agreed to pay over $5 million to settle allegations that it reported false prescription drug pricing data to the government’s Medicare program.

Federal investigators say CVS’ RxAmerica subsidiary reported false information about the prices of generic prescription drugs between 2007 and 2008. The Centers for Medicare and Medicaid Services incorporated this information in an online tool, which seniors could use to estimate their out-of-pocket drug expenses.

Commands